跳到正文
WorldBrand.AI

Anxo Pharmaceutical Co.

争议事件

以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。

返回词条共 1 条

  1. 2026

    食藥署因雜質問題下令回收心臟藥品「必克樂」膜衣錠

    宣布召回

    衛生福利部食品藥物管理署下令回收由安成藥業供應、批號BCLA91的「必克樂」膜衣錠5毫克共58.6萬顆。此令源於供應商通報，近期安定性試驗中雜質含量已達規格上限，可能影響藥品品質與療效。該公司被要求在8月31日前完成回收，並提交回收報告及矯正預防措施。

    卫生福利部食品药物管理署下令回收由安成药业供应、批号BCLA91的「必克乐」膜衣锭5毫克共58.6万颗，原因是供应商通报近期安定性试验中杂质含量已达规格上限，可能影响药品品质与疗效。该公司被要求在8月31日前完成回收，并提交回收报告及矫正预防措施。

    品牌回应

    • 召回 — Anxo Pharmaceutical Co.

      The recall of Biocor Film-Coated Tablets 5 mg, supplied by Anxo Pharmaceutical Co. and bearing batch number BCLA91, was announced by the TFDA on Wednesday.

    来源摘录

    • The Taiwan Food and Drug Administration (TFDA) has ordered the recall of 586,000 tablets of a heart medication because of impurities that could potentially affect its efficacy.
    • Liu said the company was ordered to complete the recall by Aug. 31 and submit a recall report, along with corrective and preventive measures to avoid similar problems in the future.
    • The recall of Biocor Film-Coated Tablets 5 mg, supplied by Anxo Pharmaceutical Co. and bearing batch number BCLA91, was announced by the TFDA on Wednesday.
    来源